Impact of β-adrenergic blockade on efficacy of immunotherapy in patients with metastatic clear cell renal cell carcinoma

被引：0
|
作者：
Semaan, Karl
Eid, Marc
Saad, Eddy
Issa, Wadih
Saliby, Renee Maria
Paul, Morgan
Zhong, Caiwei
Gunenc, Damla
Phillips, Noa
Nawfal, Rashad
Machaalani, Marc
Chehade, Razane El Hajj
Yekeduz, Emre
Labaki, Chris
El Zarif, Talal
Baca, Sylvan C.
Xie, Wanling
McGregor, Bradley Alexander
Zhang, Tian
Choueiri, Toni K.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas Southwestern, Dept Internal Med, Div Hematol & Oncol, Dallas, TX USA
[3] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[5] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16529
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
    Porta, Camillo
    Chiellino, Silvia
    Ferrari, Alessandra
    Mariucci, Sara
    Liguigli, Wanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 205 - 216
  • [32] Is abnormal coagulation a possible prognostic factor for efficacy of immunotherapy in metastatic renal cell carcinoma patients?
    Madzhuga, A.
    Tsimafeyeu, I.
    Demidov, L.
    Somonova, O.
    Yelizarova, A.
    THROMBOSIS RESEARCH, 2007, 120 : S165 - S166
  • [33] Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma
    Reimers, Melissa A.
    Figenshau, Robert S.
    Kim, Eric H.
    Tucker, Julie
    Kasten, Nicole
    Khan, Adeel S.
    Hanneken, Jan M.
    Smith, Zachary L.
    Hsieh, James J.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (05) : 361 - 366
  • [34] Novel immunotherapy in metastatic renal cell carcinoma
    Cho, Yang Hyun
    Kim, Myung Soo
    Chung, Ho Seok
    Hwang, Eu Chang
    INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (04) : 220 - 227
  • [35] Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
    Lukas Scheipner
    Stefano Tappero
    Mattia Luca Piccinelli
    Francesco Barletta
    Cristina Cano Garcia
    Reha-Baris Incesu
    Simone Morra
    Andrea Baudo
    Zhe Tian
    Fred Saad
    Shahrokh F. Shariat
    Carlo Terrone
    Ottavio De Cobelli
    Alberto Briganti
    Felix K. H. Chun
    Derya Tilki
    Nicola Longo
    Luca Carmignani
    Martin Pichler
    Georg Hutterer
    Sascha Ahyai
    Pierre I. Karakiewicz
    World Journal of Urology, 2023, 41 : 2991 - 3000
  • [36] The efficacy and safety of belzutifan inhibitor in patients with advanced or metastatic clear cell renal cell carcinoma: a meta-analysis
    Ge Song
    Song Xue
    Yingming Zhu
    Chunling Wu
    Xiaowei Ji
    BMC Pharmacology and Toxicology, 25 (1)
  • [37] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
  • [38] Regional immunotherapy for metastatic renal cell carcinoma
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2002, 41 (03): : 239 - 248
  • [39] IMMUNOTHERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    BELLDEGRUN, A
    FIGLIN, R
    HAAS, G
    DEKERNION, J
    WORLD JOURNAL OF UROLOGY, 1991, 9 (03) : 157 - 159
  • [40] IMMUNOTHERAPY (IT) OF METASTATIC RENAL-CELL CARCINOMA
    BUKOWSKI, RM
    GROPPE, C
    REIMER, R
    WEICK, J
    HEWLETT, JS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 402 - 402
12345